5 terminated. 5 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 5 | Terminated 5 |
| Phase 1 | 1 | Terminated 1 |
Follow Ethanol: new trials by email Literature Review of Ethanol trials Research Report on Ethanol
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Antiseptic Mouthwash / Pre-Procedural Rinse on SARS-CoV-2 Load (COVID-19) Oral-B Mouth Sore mouthwash, Crest Pro-Health Multi-Protection mouthwash, CloSYS Ultra Sensitive Rinse mouthwash - COVID-19, SARS-CoV 2 | Phase 2 | Terminated | University of California, San Francisco | 54 | 2021-03-31 | 2023-11-18 |
| Mouth Rinses for Inactivation of COVID-19 0.9% w/v NaCL Saline, 1.5% w/v Hydrogen Peroxide, 0.12% Chlorohexidine Gluconate - Covid19, Coronavirus Infection | Phase 2 | Terminated | University of North Carolina, Chapel Hill | 128 | 2020-12-18 | 2024-03-25 |
| Efficacy Study to Evaluate Antimicrobial Effectiveness of ZuraPrep™ Chloraprep, ZuraPrep, ZuraPrep Vehicle - Surgical Site Infection | Phase 2 | Terminated | Zurex Pharma, Inc. | 64 | 2014-08-01 | 2016-07-18 |
| Prophylactic Ethanol Lock Therapy (ELT) in Patients on Home Parenteral Nutrition Ethanol, Heparin Lock, Normal Saline - Catheter-related Bloodstream Infection (CRBSI) Nos, Bloodstream Infection Due to Central Venous Catheter | Phase 1 / Phase 2 | Terminated | Mayo Clinic | 39 | 2014-07-01 | 2017-12-12 |
| Catheters Dysfunction Rate After Instillation of Ethanol 60% Lock Solution in Tunneled Silicone Catheter of Chronic Hemodialysis Patients Ethanol - End Stage Renal Failure, Hemodialysis | Phase 2 | Terminated | University Hospital, Clermont-Ferrand | 40 | 2007-06-01 | 2008-10-08 |
COVID-19 (2) · Coronavirus Infections (2) · Infections (1) · Pharyngeal Diseases (1) · Pyloric Stenosis, Hypertrophic (1) · Renal Insufficiency, Chronic (1) · Surgical Wound Infection (1) · Virus Diseases (1)
Mayo Clinic (1) · University Hospital, Clermont-Ferrand (1) · University of California, San Francisco (1) · University of North Carolina, Chapel Hill (1) · Zurex Pharma, Inc. (1)
United States (4) · France (1)
Bertrand Souweine, Pr (1) · Chris Beausoleil (1) · Laura Jacox, DMD, PhD (1) · Ryan Hurt, MD, PhD (1) · Stuart A Gansky, DrPH (1)